eXmoor pharma, the full-service cell and gene therapy (CGT) manufacturing partner, launched its new Cell and Gene Therapy Centre good manufacturing practice (GMP) facility on Oct. 11, 2023 to support the production of multiple therapies for clinical trials. According to the press release, the 65,000-square-foot facility is designed with the capacity and capability to help scale the next generation of CGTs for human trials and beyond. Source: Biopharm International 12/10/2023